You have visited the Greek website of GENESIS Pharma. To learn more about our activity in Central and Eastern Europe, please visit

genesis slider

Business Development

Some of the largest biopharmaceutical companies in the world have chosen to cooperate with GENESIS Pharma, acknowledging its long-term expertise in pharmaceutical sales, marketing and distribution in the countries in which it operates, powerful growth process and commitment to excellence, quality and responsibility.

The strong network of its strategic partnerships includes leading international pharma companies committed to cutting-edge R&D as well as biopharma companies with disruptive innovations for the development of targeted, specialized treatments for orphan diseases. Biogen, Alnylam, Seagen, Incyte, Jazz Pharmaceuticals, CSL Vifor, Amicus Therapeutics and Kyowa Kirin are among its partners.

For the effective monitoring of global developments in the field of pharmaceutical research and development, GENESIS Pharma has created a specialized Business Development Department.

The Business Development department focuses on exploring, identifying and assessing possible future collaborations for products that are either before or in the approval process by the US Medicines Agency (FDA) or the European Medicines Agency (EMA).